Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information


Optimizing nocturnal diabetes control

hrp0086s3.1 | Optimizing nocturnal diabetes control | ESPE2016

Sleep and Glycaemic Control in Children with Type 1 Diabetes

Spiegel Karine

Rapidly accumulating epidemiologic and experimental evidence has indicated that insufficient sleep, such as commonly experienced in modern societies by all age groups, reduces insulin sensitivity and impairs glucose metabolism in healthy adults, and increases the risk of incident type 2 diabetes. Studies in type 1 or type 2 diabetic adults show a link between reduced sleep quality or duration and poor glyceamic control. While poor diabetes control may impair sleep due to noctu...

hrp0086s3.2 | Optimizing nocturnal diabetes control | ESPE2016

Optimising Nocturnal Glucose Control in Children with T1D: Therapeutic Implications

Danne Thomas

Background: Nocturnal hypoglycemia is not regularly predictable on the basis of a bedtime BG level and can only be confirmed by BG tests at regular intervals during the night or continuous glucose monitoring (CGM).Objective and hypotheses: A bedtime snack containing carbohydrate as well as fat and protein may be useful in preventing nocturnal hypoglycemia, but this should not be at the expense of high overnight BG levels. In many individuals, a lowering ...

hrp0086s3.3 | Optimizing nocturnal diabetes control | ESPE2016

Optimizing Nocturnal Diabetes Control: Optimising Insulin Delivery with New Technology: But Where is the Evidence?

Hovorka Roman

The use of insulin pumps is increasing particularly in the paediatric population with between 50% to 74% pump users below the age of 6 years. Real-time continuous glucose monitoring enables greater understanding of glucose excursions, provides low and high glucose alarms, and facilitates more responsive insulin dose adjustments. An enhancement of the sensor-augmented insulin therapy pump is the low-glucose suspend (LGS) and predictive low glucose management (PLGM) features red...